Whole-body spectroscopy (BCM) in the assessment of normovolemia in hemodialysis patients.
Whole-body impedance spectroscopy (BCM) has been validated by comparing isotope dilution methods for precisely measuring body volume compartments. Clinical assessment as well as comparison to other methods shows that BCM predicts a reliable individual dialysis target weight in kilograms, which corresponds to a physiological (normal) extracellular volume. BCM is helpful in the management of volume status and arterial hypertension in hemodialysis patients as well as in patients with chronic kidney disease. Quantified by BCM, overhydration is a powerful predictor of death in hemodialysis patients.